Natália Luiza Kops1,2, Manoela A Vivan3, Jaqueline D C Horvath4,5, Mariana L D de Castro4, Rogério Friedman4,6. 1. Post-Graduate Program in Endocrinology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil. nataliakops@hotmail.com. 2. Hospital Moinhos de Vento, Rua Tiradentes, 198, Porto Alegre, Rio Grande do Sul, 90560-030, Brazil. nataliakops@hotmail.com. 3. Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil. 4. Post-Graduate Program in Endocrinology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil. 5. Hospital Moinhos de Vento, Rua Tiradentes, 198, Porto Alegre, Rio Grande do Sul, 90560-030, Brazil. 6. Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Abstract
PURPOSE: Differences in weight loss outcomes after bariatric surgery may be related to individual preoperative characteristics. The aim of this study was to evaluate the potential effect of fatty acid binding protein-2 (rs1799883), leptin receptor (LEP223, rs1137101 and LEP656, rs1805094), and fat mass and obesity-related (rs9939609) genotypes on weight loss 2 years after bariatric surgery in Brazilian patients. MATERIALS AND METHODS: Prospective observational study involving 105 patients (lost to follow-up, 25.7%). In the preoperative period, patients were clinically evaluated and a fasting blood sample for genetic analysis (by real-time DNA amplification technique) was collected. From the patient's medical records, follow-up weight loss (3, 6, 12, 24 months) was obtained. Percentage of excess weight loss (%EWL) was examined by pairwise comparison across the polymorphisms. RESULTS: At baseline, the mean weight was 127.5 (23.3) kg and age 43.1 (10.9) years old. The %EWL was significant over time (p < 0.01). Only the LEP223 genotype showed association (p < 0.01). Up to 6 months after surgery, no differences were observed. At 12 months, a significant difference (p = 0.03) between AA (n = 19) and GG (n = 34) groups was observed, with 76.5% EWL versus 52.0%, respectively. This difference remained at 24 months. Other genotypes did not present any significant association. CONCLUSIONS: There is a different evolution of weight loss in carriers of the LEP223 after bariatric surgery. The AA genotype seems to be associated with a higher weight loss. However, this pattern was evident only at 12 months after surgery.
PURPOSE: Differences in weight loss outcomes after bariatric surgery may be related to individual preoperative characteristics. The aim of this study was to evaluate the potential effect of fatty acid binding protein-2 (rs1799883), leptin receptor (LEP223, rs1137101 and LEP656, rs1805094), and fat mass and obesity-related (rs9939609) genotypes on weight loss 2 years after bariatric surgery in Brazilian patients. MATERIALS AND METHODS: Prospective observational study involving 105 patients (lost to follow-up, 25.7%). In the preoperative period, patients were clinically evaluated and a fasting blood sample for genetic analysis (by real-time DNA amplification technique) was collected. From the patient's medical records, follow-up weight loss (3, 6, 12, 24 months) was obtained. Percentage of excess weight loss (%EWL) was examined by pairwise comparison across the polymorphisms. RESULTS: At baseline, the mean weight was 127.5 (23.3) kg and age 43.1 (10.9) years old. The %EWL was significant over time (p < 0.01). Only the LEP223 genotype showed association (p < 0.01). Up to 6 months after surgery, no differences were observed. At 12 months, a significant difference (p = 0.03) between AA (n = 19) and GG (n = 34) groups was observed, with 76.5% EWL versus 52.0%, respectively. This difference remained at 24 months. Other genotypes did not present any significant association. CONCLUSIONS: There is a different evolution of weight loss in carriers of the LEP223 after bariatric surgery. The AA genotype seems to be associated with a higher weight loss. However, this pattern was evident only at 12 months after surgery.
Entities:
Keywords:
Bariatric surgery; Genotype; Polymorphism; Weight loss
Authors: M A Sarzynski; P Jacobson; T Rankinen; B Carlsson; L Sjöström; C Bouchard; L M S Carlsson Journal: Int J Obes (Lond) Date: 2010-08-24 Impact factor: 5.095
Authors: Gisele K Rodrigues; Cristina M M Resende; Danielle F Durso; Lorena A A Rodrigues; José Luiz P Silva; Rodrigo C Reis; Solange S Pereira; Daniela C Ferreira; Gloria R Franco; Jacqueline Alvarez-Leite Journal: Nutrition Date: 2015-06-25 Impact factor: 4.008
Authors: Daniel A de Luis; Manuel González Sagrado; Olatz Izaola; Maria Concepcion Terroba; Luis Cuellar; Rosa Conde; Tomas Martin Journal: Nutrition Date: 2008-02-15 Impact factor: 4.008
Authors: Genevieve B Melton; Kimberley E Steele; Michael A Schweitzer; Anne O Lidor; Thomas H Magnuson Journal: J Gastrointest Surg Date: 2007-12-11 Impact factor: 3.452
Authors: Angelo Scuteri; Serena Sanna; Wei-Min Chen; Manuela Uda; Giuseppe Albai; James Strait; Samer Najjar; Ramaiah Nagaraja; Marco Orrú; Gianluca Usala; Mariano Dei; Sandra Lai; Andrea Maschio; Fabio Busonero; Antonella Mulas; Georg B Ehret; Ashley A Fink; Alan B Weder; Richard S Cooper; Pilar Galan; Aravinda Chakravarti; David Schlessinger; Antonio Cao; Edward Lakatta; Gonçalo R Abecasis Journal: PLoS Genet Date: 2007-07 Impact factor: 5.917